Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

OICR-12694 is an inhibitor of Bcl-6.1 It binds to the BTB domain on Bcl-6 (Kd = 5 nM in a surface plasmon resonance (SPR) assay). OICR-12694 decreases transcription of Bcl-6-targeted genes in a reporter assay using SU-DHL-4 cells (EC50 = 89 nM). It reduces the proliferation of Karpas-422 large B cell lymphoma cells (IC50 = 92 nM).
WARNING This product is not for human or veterinary use.
1. Discovery of OICR12694: A novel, potent, selective, and orally bioavailable BCL6 BTB inhibitor. ACS Med. Chem. Lett. 14(2), 199-210 (2023).